Ayurvedic products giant Patanjali launched a new drug, Coronil which, the company claimed, is an evidence-based medicine for treatment of Covid-19, a pandemic caused by the novel coronavirus. Swami Ramdev, the yoga guru, unveiled the medicine at a press conference at Patanjali's headquarters in Haridwar, Uttarakhand.
Patanjali CEO Acharya Balkrishna had earlier this month claimed that a team of scientists had been working to develop a medicinal compound that could treat Covid-19. He claimed 100 per cent favourable results in trials. Patanjali has said the research was undertaken by a joint team of the Patanjali Research Institute (PRI) and the National Institute of Medical Sciences (NIMS), Jaipur. The product has been manufactured by Divya Pharmacy of the Patanajli. Launching the medicine, Ramdev said, "The whole world has been waiting for someone to develop a medicine for coronavirus. Today, we are proud that we developed the first ayurvedic medicine for coronavirus. It has been named Coronil."
"We conducted clinical study on 100 patients. Around 65 per cent of them returned negative test results within three days," Ramdev said. He said, "Hundred per cent patients got cured in seven days. We have prepared this medicine with adequate research. Our medicine has 100 per cent recovery rate and zero per cent death rate." Ramdev claimed that Patanjali has followed "all scientific rules" in developing this ayurvedic medicine to treat Covid-19 patients.
Read More...
